Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis
Recruiting
Phase 3
Interventional Study
Carpometacarpal Sprain
Thumb Sprain
Clostridium; Botulinum
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- Rhode Island Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this clinical trial is to gather information on the safety and effectiveness of botulinum toxin injection (or Botox) in the treatment of thumb joint pain/arthritis. People with thumb joint pain or arthritis usually receive steroid injections to help with the pain. However, this medicine does not always work well and also carries known important side effects. There is currently no al…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients (\> 18 years old) with a diagnosis of thumb CMC OA
* Diagnosis of thumb CMC OA
* History, clinical exam, and radiographic findings, as done in prior studies on this topic.
* Subjective: thumb or wrist pain at rest or with activity, joint stiffness
* Exam: basal …
Contacts